CL logo

Colgate-Palmolive Company (CL) Cash and cash equivalents

annual cash & cash equivalents:

$1.26B+$111.00M(+9.69%)
December 31, 2024

Summary

  • As of today (August 25, 2025), CL annual cash & cash equivalents is $1.26 billion, with the most recent change of +$111.00 million (+9.69%) on December 31, 2024.
  • During the last 3 years, CL annual cash & cash equivalents has risen by +$390.00 million (+45.03%).
  • CL annual cash & cash equivalents is now -18.92% below its all-time high of $1.55 billion, reached on December 31, 2017.

Performance

CL Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLbalance sheet metrics

quarterly cash & cash equivalents:

$1.41B+$101.00M(+7.70%)
June 30, 2025

Summary

  • As of today (August 25, 2025), CL quarterly cash & cash equivalents is $1.41 billion, with the most recent change of +$101.00 million (+7.70%) on June 30, 2025.
  • Over the past year, CL quarterly cash & cash equivalents has increased by +$77.00 million (+5.77%).
  • CL quarterly cash & cash equivalents is now -30.72% below its all-time high of $2.04 billion, reached on March 31, 2014.

Performance

CL quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CL Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.7%+5.8%
3 y3 years+45.0%+44.4%
5 y5 years+38.6%+38.2%

CL Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+45.0%-5.5%+48.6%
5 y5-yearat high+45.0%-5.5%+63.0%
alltimeall time-18.9%+2098.2%-30.7%+2372.8%

CL Cash and cash equivalents History

DateAnnualQuarterly
Jun 2025
-
$1.41B(+7.7%)
Mar 2025
-
$1.31B(+4.4%)
Dec 2024
$1.26B(+9.7%)
$1.26B(-15.9%)
Sep 2024
-
$1.49B(+11.9%)
Jun 2024
-
$1.33B(+1.9%)
Mar 2024
-
$1.31B(+14.4%)
Dec 2023
$1.15B(+20.5%)
$1.15B(-4.4%)
Sep 2023
-
$1.20B(+10.3%)
Jun 2023
-
$1.09B(-5.0%)
Mar 2023
-
$1.14B(+20.3%)
Dec 2022
$950.00M(+9.7%)
$950.00M(-17.1%)
Sep 2022
-
$1.15B(+17.2%)
Jun 2022
-
$978.00M(+4.6%)
Mar 2022
-
$935.00M(+8.0%)
Dec 2021
$866.00M(-6.4%)
$866.00M(-18.1%)
Sep 2021
-
$1.06B(+5.1%)
Jun 2021
-
$1.01B(-4.7%)
Mar 2021
-
$1.06B(+14.3%)
Dec 2020
$925.00M(+2.1%)
$925.00M(-13.5%)
Sep 2020
-
$1.07B(+4.6%)
Jun 2020
-
$1.02B(+13.9%)
Mar 2020
-
$897.00M(-1.0%)
Dec 2019
$906.00M(+23.1%)
$906.00M(-14.3%)
Sep 2019
-
$1.06B(+13.8%)
Jun 2019
-
$929.00M(+5.6%)
Mar 2019
-
$880.00M(+19.6%)
Dec 2018
$736.00M(-52.5%)
$736.00M(-23.4%)
Sep 2018
-
$961.00M(+4.9%)
Jun 2018
-
$916.00M(+1.1%)
Mar 2018
-
$906.00M(-41.5%)
Dec 2017
$1.55B(+11.8%)
$1.55B(-3.3%)
Sep 2017
-
$1.60B(+14.8%)
Jun 2017
-
$1.40B(-4.3%)
Mar 2017
-
$1.46B(+5.3%)
Dec 2016
$1.39B(+34.4%)
$1.39B(-10.2%)
Sep 2016
-
$1.54B(+18.9%)
Jun 2016
-
$1.30B(+12.8%)
Mar 2016
-
$1.15B(+7.4%)
Dec 2015
$1.03B(-20.0%)
$1.07B(-32.6%)
Sep 2015
-
$1.59B(+21.7%)
Jun 2015
-
$1.31B(+17.9%)
Mar 2015
-
$1.11B(-14.0%)
Dec 2014
$1.29B(+13.6%)
$1.29B(-12.8%)
Sep 2014
-
$1.48B(+12.4%)
Jun 2014
-
$1.32B(-35.4%)
Mar 2014
-
$2.04B(+79.6%)
Dec 2013
$1.14B(+13.5%)
$1.14B(+34.6%)
Sep 2013
-
$843.00M(-18.5%)
Jun 2013
-
$1.03B(-3.5%)
Mar 2013
-
$1.07B(+7.2%)
Dec 2012
$1.00B(+5.3%)
$1.00B(+1.0%)
Sep 2012
-
$990.00M(-8.4%)
Jun 2012
-
$1.08B(-4.0%)
Mar 2012
-
$1.13B(+18.5%)
Dec 2011
$950.00M(+68.4%)
$950.00M(-6.6%)
Sep 2011
-
$1.02B(+28.4%)
Jun 2011
-
$792.00M(+8.6%)
Mar 2011
-
$729.00M(+29.3%)
Dec 2010
$564.00M(-12.0%)
$564.00M(-20.5%)
Sep 2010
-
$709.00M(+16.4%)
Jun 2010
-
$609.00M(+1.2%)
Mar 2010
-
$602.00M(-6.1%)
Dec 2009
$641.00M(+13.0%)
$641.00M(-27.6%)
Sep 2009
-
$885.00M(-4.7%)
Jun 2009
-
$928.50M(+27.7%)
Mar 2009
-
$726.90M(+28.2%)
Dec 2008
$567.10M
$567.10M(-13.6%)
DateAnnualQuarterly
Sep 2008
-
$656.40M(+2.0%)
Jun 2008
-
$643.50M(-1.9%)
Mar 2008
-
$655.70M(+53.0%)
Dec 2007
$428.70M(-12.4%)
$428.70M(-31.8%)
Sep 2007
-
$628.40M(+14.9%)
Jun 2007
-
$546.90M(+15.3%)
Mar 2007
-
$474.40M(-3.1%)
Dec 2006
$489.50M(+43.7%)
$489.50M(-2.7%)
Sep 2006
-
$502.90M(+16.8%)
Jun 2006
-
$430.40M(+12.4%)
Mar 2006
-
$382.80M(+12.4%)
Dec 2005
$340.70M(+6.6%)
$340.70M(-9.5%)
Sep 2005
-
$376.30M(-4.0%)
Jun 2005
-
$392.10M(-5.3%)
Mar 2005
-
$413.90M(+80.0%)
Dec 2004
$319.60M(+50.4%)
-
Mar 2001
-
$229.90M(+4.3%)
Dec 2000
$212.50M(-9.7%)
-
Sep 2000
-
$220.50M(-7.6%)
Jun 2000
-
$238.70M(+1.5%)
Dec 1999
$235.20M(+20.9%)
$235.20M(-6.6%)
Jun 1999
-
$251.90M(+22.8%)
Mar 1999
-
$205.10M(+5.4%)
Dec 1998
$194.50M(-5.3%)
$194.50M(-14.0%)
Sep 1998
-
$226.10M(+11.1%)
Jun 1998
-
$203.60M(-9.8%)
Mar 1998
-
$225.60M(+23.2%)
Dec 1997
$205.30M(-33.3%)
$183.10M(-19.5%)
Sep 1997
-
$227.40M(-2.9%)
Jun 1997
-
$234.30M(+40.0%)
Mar 1997
-
$167.30M(-32.6%)
Dec 1996
$307.80M(+47.4%)
$248.20M(+11.5%)
Sep 1996
-
$222.70M(+17.3%)
Jun 1996
-
$189.80M(-8.3%)
Mar 1996
-
$206.90M(-0.9%)
Dec 1995
$208.80M(+22.9%)
$208.80M(-6.8%)
Sep 1995
-
$224.00M(+35.4%)
Jun 1995
-
$165.40M(-3.6%)
Mar 1995
-
$171.50M(+0.9%)
Dec 1994
$169.90M(-38.5%)
$169.90M(-6.1%)
Sep 1994
-
$180.90M(+18.6%)
Jun 1994
-
$152.50M(+3.1%)
Mar 1994
-
$147.90M(+2.6%)
Dec 1993
-
$144.10M(-15.4%)
Sep 1993
-
$170.30M(+12.8%)
Jun 1993
-
$151.00M(-14.1%)
Mar 1993
-
$175.70M(+49.0%)
Dec 1992
-
$117.90M(-30.9%)
Sep 1992
-
$170.50M(+0.2%)
Jun 1992
-
$170.20M(-16.0%)
Mar 1992
-
$202.60M(+20.2%)
Dec 1991
-
$168.50M(+31.1%)
Sep 1991
-
$128.50M(+2.4%)
Jun 1991
-
$125.50M(-5.4%)
Mar 1991
-
$132.70M(-20.3%)
Dec 1990
$276.40M(-47.3%)
$166.40M(+30.6%)
Sep 1990
-
$127.40M(-30.4%)
Jun 1990
-
$183.10M(-23.3%)
Mar 1990
-
$238.70M(-40.0%)
Dec 1989
$524.19M(+817.4%)
$397.90M(+86.6%)
Sep 1989
-
$213.20M(-41.7%)
Dec 1988
-
$365.50M(+540.1%)
Dec 1987
$57.14M(-65.4%)
$57.10M(-65.4%)
Dec 1986
$165.14M(-36.4%)
$165.10M(-36.4%)
Dec 1985
$259.46M(-23.6%)
$259.50M(-26.2%)
Dec 1984
-
$351.70M
Dec 1980
$339.43M
-

FAQ

  • What is Colgate-Palmolive Company annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Colgate-Palmolive Company?
  • What is Colgate-Palmolive Company annual cash & cash equivalents year-on-year change?
  • What is Colgate-Palmolive Company quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Colgate-Palmolive Company?
  • What is Colgate-Palmolive Company quarterly cash & cash equivalents year-on-year change?

What is Colgate-Palmolive Company annual cash & cash equivalents?

The current annual cash & cash equivalents of CL is $1.26B

What is the all time high annual cash & cash equivalents for Colgate-Palmolive Company?

Colgate-Palmolive Company all-time high annual cash & cash equivalents is $1.55B

What is Colgate-Palmolive Company annual cash & cash equivalents year-on-year change?

Over the past year, CL annual cash & cash equivalents has changed by +$111.00M (+9.69%)

What is Colgate-Palmolive Company quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of CL is $1.41B

What is the all time high quarterly cash & cash equivalents for Colgate-Palmolive Company?

Colgate-Palmolive Company all-time high quarterly cash & cash equivalents is $2.04B

What is Colgate-Palmolive Company quarterly cash & cash equivalents year-on-year change?

Over the past year, CL quarterly cash & cash equivalents has changed by +$77.00M (+5.77%)
On this page